Back to search results

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Abroad (travel likely)RecruitingPHASE2

Conditions

Inflammatory Arthritis · Immune-related Adverse Event

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • St. Joseph's Health Care, London, Ontario, Canada

    Contact: Study coordinator (Maha El-shimy) · maha.el-shimy@sjhc.london.on.ca · 519-646-6000
    Contact: Principal Investigator (Dr. Tom Appleton, MD, FRCPC, PhD)
    Dr. Janet Pope, MD, FRCPC, MPH (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)